Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.56 | -1.44 |
PEG Ratio (TTM) | 0.03 | 3.67 |
P/S Ratio (TTM) | 0.04 | 1.38 |
P/B Ratio (TTM) | 0.40 | 5.16 |
P/FCF Ratio (TTM) | -2.36 | 2.18 |
Price to 5YR AVG Earnings Ratio | N/A | 25.83 |
Price to 5YR AVG FCF Ratio | N/A | 21.03 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.36% | 5.00% |
ROE (TTM) | -9.90% | 7.26% |
Net Profit Margin (TTM) | -0.99% | 4.81% |
ROIC 5YR AVG | N/A | 13.99% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -159.95% | -251.71% | N/A |
Revenue | -1.21% | -6.23% | N/A |
Net Income | -142.84% | -250.42% | N/A |
Cash Flow | -58.42% | -72.28% | N/A |
Health (26%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.54 | 1.98 |
Quick Ratio (TTM) | 0.81 | 1.18 |
D/E Ratio (TTM) | 3.71 | 1.95 |
Interest Coverage (TTM) | -0.35 | 10.93 |
Piotroski F-Score | 5 | 7 |
Altman Z-Score | 0.58 | 3.54 |
LTL to 5YR AVG FCF | N/A | 5.72 |
Shares Outstanding Growth 5YR AVG | N/A | -0.29% |